Should You Operate or Monitor Ductal Carcinoma in Situ?

Clinical Congress Session Showcases highlight select Panel Sessions presented at Clinical Congress 2024, using the original session as a base and building on it with fresh perspectives from panelists.

On Thursday, April 24, from 6:00–7:00 pm CT, a live webinar will focus on the popular session, "Ductal Carcinomas in Situ (DCIS): Who Needs an Operation and Who Doesn't?"

The latest retrospective literature now suggests that some cases of DCIS may be treated with observation or with de-escalation, and soon the results of the Comparison of Operative to Monitoring and Endocrine Therapy for low-risk ductal carcinoma in situ (COMET) trial will determine if observation of DCIS is safe in certain patients. While observation of DCIS may be on the horizon, there are many patients who will continue to require multimodal therapy.

This session will summarize the latest literature on this ever-changing topic and emphasize an important surgeon lesson: when not to operate.

Medical Student Members and Clinical Congress 2024 attendees can participate for free; all others will pay a nominal fee.

During the live webinar, each speaker will highlight the key educational content covered at Clinical Congress and reinforce important points from their presentations. The recording will be available on demand on the course site after the webinar.

Learn more and register.